FLUTICASONE PROPIONATE NASAL SPRAY

The Defense Logistics Agency awarded a delivery order under the basic contract SPE2DX25D8022 to Cardinal Health, Inc. (CAGE 00E55) for the supply of Fluticasone Propionate Nasal Spray, identified by NSN 6505014107226, at a total price of $68.40. The award was issued on July 18, 2026, with delivery required by July 20, 2026, to the destination address USS CHARLESTON LCS 18, UNIT 100474 BOX 1, FPO AP 96694, United States. The contract specifies FOB Destination terms, placing all transportation costs and risk on the contractor, and mandates shipment via the fastest traceable means with explicit prohibition against Parcel Post. All packaging and documentation must be marked with the base contract number SPE2DX25D8022 and the delivery order number SPE2D926F7435. The product must comply with applicable DoD medical supply standards and is subject to government inspection and acceptance at the destination. Cardinal Health, Inc. is designated as a small business with claimed status as both a Small Disadvantaged Business and a Women-Owned Small Business, triggering obligations under FAR 52.219-26 and FAR 52.219-28 for verification and reporting through SAM. No specific quality standards, packaging specifications, or military standards such as MIL-STD-129 are cited, and no bar-coding, preservation, or special labeling requirements beyond identification numbers are included. The contract contains no option quantities, variation ranges, or clauses beyond administrative delivery terms and represents a single-line-item transaction under an indefinite delivery vehicle. Payment is to be processed through the Defense Finance and Accounting Service with remittance addressed to P.O. Box 182317, Columbus, OH 43218-2317, using payment code SL4701. The contracting officer is Lisa Quinn, and administrative support is provided by Michelle Pampel. The award was likely made using a Lowest Price Technically Acceptable approach due to the minimal value and lack of detailed evaluation factors.